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Osteosarcoma is the most frequent malignant bone tumour second
to multiple myeloma. Molecular analyses have revealed the pres-
ence of somatic mutations in two tumour suppressor genes, the
retinoblastoma (Rb) and p53 genes, in more than 60% of cases
respectively (Toguchida et al, 1992; Wadayama et al, 1994). In
addition, hereditary mutations of these genes predispose individ-
uals to osteosarcomas, suggesting the important roles of these
mutations in the development of this type of tumour (Friend et al,
1987; Malkin et al, 1990). Mutations of genes which are function-
ally related to the Rb or p53 genes were found in some tumours
with no apparent mutations of the Rb or p53 genes themselves,
indicating the presence of alternative mechanisms to inactivate the
tumour suppressor functions (Oliner et al, 1992; Khativ et al,
1993). There are, however, some tumours without any detectable
mutations in molecules on either the Rb- or p53-pathway. These
tumours may have some other genetic alterations which are equiv-
alent with loss-of-function mutations of the tumour suppressor
genes.
Simian virus 40 (SV40) is a member of poliomavirus, which is
semipermissive in the human cells; the virus could both replicate
in and transform human cells (Fanning and Knippers, 1992). The
ability of SV40 to transform cells depends mainly on the function
of large T antigen (Tag), which makes complexes with several
tumour suppressor proteins, such as Rb and p53 and induce cell
division (Fanning and Knippers, 1992). The first evidence for the
presence of SV40-like sequences in human tumours was shown in
brain tumours (Bergsagel et al, 1992). The results were confirmed
by reports from other laboratories (Lednicky et al, 1995; Martini
et al, 1996), and SV40-like sequences were also found in meso-
theliomas (Carbone et al, 1994), bone tumours (Carbone et al,
1996) and papillary thyroid carcinomas (Pacini et al, 1998), all of
which were tumours found in SV40-infected or transgenic rodents
(Diamandopoulos, 1972; Ledent et al, 1991; Cicala et al, 1993). In
the case of osteosarcomas, however, the incidence of SV40-like
sequences varied greatly depending on the sample sources
(Carbone et al, 1996). In the case of mesothelioma, it was shown
that the presence of SV40-like sequence resulted in the expression
of Tag protein, which binds to p53 (Carbone et al, 1997). No data,
however, were reported whether the Tag was expressed in
osteosarcoma tumours containing SV40-like sequences. There is
also a discordance about the incidence of SV40-like sequences in
normal tissues. In the initial report by Bergsagel et al no SV40-like
sequences was detected in 100 blood specimens from normal
controls (Bergsagel et al, 1992), whereas Martini et al found
SV40-like sequences in 23% of peripheral blood samples from
normal individuals (Martini et al, 1996). No data were presented
concerning this point in osteosarcoma patients, and it will be
intriguing to compare the incidence of SV40-like sequences in
peripheral blood cells between patients and healthy controls,
which may address the role of SV40-like sequences in osteo-
sarcomas.
In this report, we have addressed the above mentioned issues
using Japanese osteosarcoma samples, in which we have already
performed intensive DNA-based analyses for tumour suppressor
gene mutations.
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MDM2, and CDK4 genes had been already analysed. Using polymerase chain reaction and Southern hybridization, SV40-like sequences
were detected in 25 cases (46.3%). In most cases, only a part of SV40 genome was detected, and the regulatory region containing enhancer
sequences was most frequently found (21/54, 38.9%). There was no apparent relationship between the presence of SV40-like sequences
and tumour suppressor genes mutations in each tumour. The SV40-like sequences were also detected in peripheral blood cells of substantial
proportion of the patients (43.3%), whereas the incidence was much lower (4.7%) in normal healthy controls. This difference is statistically
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MATERIALS AND METHODS
DNA extraction
Osteosarcoma tumour tissues were obtained at the time of surgery
from 54 patients whose age ranged from 3 to 25 years at the diag-
nosis (mean age 15.8 years). All patients received the preoperative
chemotherapy by the combination of two or three anticancer drugs
including doxorubicin, cis-platinum and methotrexate. Tumour
tissues were quickly frozen and kept in –80°C until DNA extrac-
tion. Whole blood sample was collected from the corresponding
patients in 30 cases before or after the surgery of the primary
lesion, and also from 64 healthy volunteers (mean age 24.4 years)
who were born after 1965. High-molecular-weight-DNAs were
extracted from tumour tissues and whole blood cells as previously
described (Sambrook et al, 1989).
PCR and Southern blot analysis
DNAs were extracted from each sample, and 100 ng of DNAs
were used as templates for polymerase chain reaction (PCR)
containing 10 pmol of each primer, 0.2 mM dNTP, 1.5–2.5 mM of
magnesium chloride and 0.1 units of rTaq polymerase (Toyobo,
Shiga, Japan). After completion of the first 30 cycles, 0.1 units of
rTaq was added, and another 30 cycles of amplifications were
performed. Primers to amplify each region of SV40 used were: for
a 315 bp region of the regulatory region (R region), R1 (AATGT-
GTGTCAGTTAGGGTGTG) and R2 (TCCAAAAAAGCCTC-
CTCACTACTT); for a 574 bp region encompassing the Rb-pocket
binding domain of Tag (N region), SVfor2 (CTTTGAG-
GCTTCTGGGATGCAACT), and SVrev (GCATGACTCAA-
AAAACTTAGCAATTCTG); for a 443 bp region of the
carboxyl-terminal domain of Tag (C region), T1 (GACCTGTG-
GCTGAGTTTGCTCA) and T2 (GCTTTATTTGTAACCAT-
TATAAG). Sequences of these primers were derived from a
previously published study (Lednicky et al, 1995). The PCR prod-
ucts were electrophoresed in 2% agarose gel, transferred to nylon
membrane (Hybond-N+, Amersham Pharmacia Biotech), and
hybridized with 32P-labelled fragments generated by PCR using
same primers from DNA of 509SV, which is a SV40-transfected
human liposarcoma cell line (T Nakayama, unpublished data). The
sequences of these fragments were confirmed by sequencing and
were found to be identical with those of the published SV40
genome (Reddy et al, 1978) (data not shown). We repeated these
experiments using internal oligonucleotide primers used in a
previous study (Carbone et al, 1996), and obtained the same
results (data not shown).
RESULTS
Presence of SV40-like sequences in osteosarcoma
tumours
In 54 tumour samples, 25 tumours (46.3%) were found to contain
at least one of the three regions of SV40-like sequences (Figure 1
and Table 1). In most cases, the size of amplified SV40-like
sequences was identical with that of control fragments which were
amplified using DNA from a SV40-transfected cell line, but some
samples showed fragments with a slightly different size (for
example, sample 238 in Figure 1A). Most of the fragments were
detected only after Southern blot analyses, but some were visible
in the ethidium-bromide-staining gel after the second round of
PCR. One fragment amplified by using primers specific to the
regulatory (R) region and another fragment amplified by using
primers specific to the amino-terminal (N) region including the
‘Rb-pocket’ binding domain were gel-purified and directly
sequenced. The sequences of both fragments were completely
identical with the corresponding authentic sequences of SV40
genome (Reddy et al, 1978 and data not shown).
Table 1 SV40-like sequences in osteosarcoma samples
Regions positive for SV40-like
sequencesa No. of cases
R+N+C 1
R+N 2
R+C 2
R1 6
N+C 1
N1
C2
Total positive/total samples 25/54 (47%)
aR, regulatory region; N, amino-terminal region containing the Rb-pocket 
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Figure 1 Detection of SV40-like sequences in osteosarcoma tumours.
Numbers on the top of each lane indicate the ID number of each sample.
No DNA indicates PCR products without template DNA, and 509SV indicates
PCR products using DNA isolated from a liposarcoma cell line transfected
with the expression vector containing the replication defective SV40. (A) the
regulatory (R) region; (B) the amino-terminal (N) region containing the
Rb-pocket domain; (C) the carboxyl-terminal (C) region. Primers for each
PCR and probes for hybridization are described in Materials and Methods
section. Numbers on the right side indicate the position of each fragment of
HincII digested jX174 DNAsSV40 sequences in Japanese osteosarcomas 1679
British Journal of Cancer (2000) 82(10), 1677–1681 © 2000 Cancer Research Campaign
Among 25 samples with SV40-like sequences, only one case
showed amplified fragments from all of the three regions, while
amplified fragments were detected only in one or two of three
regions in other 24 samples (Table 1). Fragments from the R
region were found most frequently (21/54, 38.9%), followed by
carboxyl-terminal (C) region (6/54, 11.1%), and the frequency of
the N region was the lowest (5/54, 9.3%). There were two cases in
which only R and C regions, but not N region were amplified
(Table 1).
Relationship with the status of genes on the Rb- and
p53 gene pathways
Mutations analyses of the Rb, p53, MDM2, and CDK4 genes had
been performed in 32 of 54 osteosarcomas used in this study, and
the results were reported previously (Toguchida et al, 1992;
Wadayama et al, 1994; Nakayama et al, 1995; Kanoe et al, 1998).
The status of the Rb gene was defined as Rb(mut) for a tumour
with a mutation in the Rb gene or amplification of the CDK4 gene
(19 cases), and other tumours were defined as Rb(wt) (13 cases)
(Table 2). In the case of the p53 gene, tumours were defined as
p53(mut) for a tumour with a mutation in the p53 gene or amplifi-
cation of the MDM2 gene (19 cases), and others were defined as
p53(wt) (13 cases). The incidence of SV40-like sequences in
tumours with Rb(wt) and Rb(mut) showed no significant differ-
ence (38.5% vs 47.4%; P = 0.618, c2 test). The status of the p53
gene also showed no significant relationship with the incidence
(53.8% vs 36.8%; P = 0.341, c2 test). Furthermore, 32 cases were
categorized into four groups based on the status of Rb and p53
genes; Rb(wt)/p53(wt) in five cases, Rb(wt)/p53(mut) in eight
cases, Rb(mut)/p53(wt) in eight cases, and Rb(mut)/p53(mut) in
11 cases (Table 2). Similar to the results of the analyses for each
gene, there was no statistically significant difference in the inci-
dence of SV40-like sequences among these groups (P = 0.611,
c2 test).
Presence of SV40-like sequences in peripheral blood
cells DNA
DNAs from peripheral blood cells (PBCs) were available from 30
patients among 54 cases in this study, and SV40-like sequences
were detected in 13 cases (43.3%) (Figure 2 and Table 3). The inci-
dence of R region was the highest (7/30, 23.3%) as same as the
results in tumours, followed by the C region (6/30, 20%) and the
N region (3/30, 10%). The presence of SV40-like sequences in
tumour samples was not apparently associated with that in the
corresponding PBCs (Table 4). SV40-like sequences were ampli-
fied from PBCs but not from tumours in five patients, and only two
cases among eight in which SV40-like sequences were detected in
both tumour and PBC DNAs showed an identical pattern of ampli-
fied regions. Among the 64 age-matched healthy volunteers, only
three (4.7%) were found to have SV40-like sequences in PBC
genome (Table 3), and the difference in incidence between
the patient and control group was statistically highly significant
(P < 0.0001, c2 test).
Table 2 Relationship between the status of tumour suppressor genes and the presence of SV-40 like sequences
SV-40 like sequences
Genes Mutation
status No. of positive No. of negative % of positive
cases cases cases
Rb wt 5 8 38.5
mut 9 10 47.4
p53 wt 7 6 53.8
mut 7 12 36.8
Rb/p53 wt/wt 3 2 60.0
wt/mut 2 6 25.0
mut/wt 4 4 50.0
mut/mut 5 6 45.5
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Figure 2 Detection of SV40-like sequences in peripheral blood cells from
osteosarcoma patients. See details in the legend for Figure 1. (A) The
regulatory (R) region; (B) the amino-terminal (N) region containing the Rb-
pocket domain; (C) the carboxyl-terminal (C) region 1680 H Yamamoto et al
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DISCUSSION
The incidence of SV40-like sequences in osteosarcoma tumours in
this study (25/54, 46.3%) is compatible with previous three
reports: 40/126 (31.7%), 5/10 (50%), and 9/35 (25.7%) (Carbone
et al, 1996; Lednicky et al, 1997; Mendoza et al, 1998). In the case
of mesothelioma, the expression of Tag protein was detected by
Western blot analyses and immunohistochemical studies, indi-
cating the presence of the entire coding region of Tag in tumour
cells (Carbone et al, 1997). In the case of osteosarcomas in this
study, however, only a part of Tag genome was detected in most
cases, and most of the fragments were detected only by Southern
blot analyses after 60 cycles of amplification, suggesting that the
SV40-like sequences were not present in each tumour cell. We
have no clear explanation for our detection of only a part of SV40
genome in most cases. Severe tumour necrosis due to the pre-
operative chemotherapy may cause the degradation of DNA,
which may affect the sensitivity of detection. Most of DNA
samples, however, were able to be used in Southern blot analyses
of the Rb or p53 genes, which require high-molecular-weight
DNA with much better quality than those required in the PCR
analyses. Therefore, the reason for the failure to detect the entire
region of SV40 genome was not merely due to the poor quality of
DNA. Since genomic instability is one of the important character-
istics of malignant cells, it is not unlikely that the SV40 genome
might be rearranged after exerting its role in earlier stages of
multistep tumorigenesis in osteosarcomas, and the observed
results are merely reminiscent of such events, as proposed in the
case of papilloma virus infection in cervical cancers (zur Hausen,
1996). Alternatively, the presence of a part of SV40-like
sequences itself may have some mechanistic role to play. The most
frequently detected region in SV40 genome in this study is the
regulatory region sequence (21/54 in tumour samples). The
sequence of this region contains a transcription enhancer element
which is able to activate the expression of genes in either orienta-
tion (Fanning and Knippers, 1992), and it was shown that the inte-
grated sequence of this region produced fusion transcripts in
SV40-infected human keratinocytes (Chen et al, 1996). Therefore,
some genes flanking the integrated SV40 sequences are possibly
up-regulated to endow cells with enhanced proliferation activity,
although we did not confirm whether SV40 genome detected in
our samples was integrated into the genomic DNA.
There is no definite correlation between the presence of SV40-
like sequences and mutations of tumour suppressor genes in our
samples. Mendoza et al also found no correlation of the presence
of Tag-like sequences with tumour suppressor inactivation in
osteosarcomas (Mendoza et al, 1998). These results are in contrast
with those of mesotheliomas, in which no p53 gene mutation was
detected in most cases with the expression of Tag (Carbone
et al, 1997). SV40-like sequences in osteosarcomas might not be
related with the function of Tag as an inactivator of tumour
suppressor genes.
The major source of human exposure to SV40 is considered to
be the contaminated vaccines for poliomyelitis (Shah and
Nathanson, 1976). In 1961, shortly after the discovery of SV40
(Sweet and Hilleman, 1960), mass administration of Sabin vaccine
was carried out in Japan, because of an outbreak of poliomyelitis
in the previous year (5606 cases in 1960) (Takatsu et al, 1973). In
the following 2 years, 1962 and 1963, mass vaccination was also
performed and almost all Japanese children from 3 months to 12
years of age received live oral vaccine imported from Canada and
USSR, which might have had a higher titre of SV40 contamination
(Shah and Nathanson, 1976). Therefore, although the length of
period when the contaminated vaccine was used was much shorter
than in the USA, a considerable fraction of people in Japan at that
age were at risk of infection by SV40. None of the individuals in
this study, however, either patients or healthy controls, were born
before 1965, and therefore they should have had the lowest risk 
of receiving contaminated vaccine. Nevertheless, the SV40-like
sequences were present in tumour and also in normal cells,
suggesting the unknown mechanisms for SV40 to spread over the
population.
In terms of the presence of SV40-like sequences in PBCs, our
results agreed with the data by Martini et al using brain tumour
cases (Martini et al, 1996), and disagreed with the data by
Bergsagel et al (1992), although we have no clear explanation of
this discrepancy. The difference of incidence of SV40-like
sequences between osteosarcoma patients and healthy volunteers is
quite an intriguing matter. Because PBCs were collected from
patients in tumour-bearing condition in most cases, there is a possi-
bility that the origin of amplified SV40-like sequences in patients is
not from peripheral leucocytes, but from circulating tumour cells.
However, SV40-like sequence was also detected from PBCs
collected from patients in an apparently tumour-free condition after
tumour resection. There was poor correlation between finding
SV40-like sequence in tumour tissue and in PBCs in each patient.
Although viral involvement may occur at the same time in all
tissues, the process to maintain or eliminate the viral genome may
be different in each type of tissue, causing different patterns of the
reminiscence of SV40 sequences. Although there were such
perplexing data to be resolved, the difference of incidence of 
SV40-like sequences was clear between PBCs from osteosarcoma
patients and control individuals, suggesting some role for 
Table 3 SV40-like sequences in peripheral blood cells
Regions positive for 
No. of cases
SV40-like sequencesa Osteosarcoma patients Healthy controls
R+N+C 0 0
R+N 1 0
R+C 1 0
R5 0
N+C 1 0
N1 1
C4 2
Total positive/total samples 13/30 (43.3%) 3/64 (4.7%)
aR, regulatory region; N, amino-terminal region containing the Rb-pocket
binding domain; C, carboxyl-terminal region.
Table 4 SV-40 like sequences in tumours and peripheral blood cells of
osteosarcoma patients
SV40-like sequences
SV40-like sequences
in PBCs
in tumours No. of positive No. of negative
cases cases
Positive 8 8
Negative 5 9SV40 sequences in Japanese osteosarcomas 1681
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SV40-like sequences in the development of osteosarcoma. Further
nationwide studies may provide us with the answer to this question.
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